These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24780944)

  • 1. Can dietary integrators provide a clinical benefit in the treatment of functional dyspepsia? results from a prospective study with TUBES Gastro.
    Molteni M
    Minerva Gastroenterol Dietol; 2014 Jun; 60(2):105-12. PubMed ID: 24780944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of dietary integrators for treating functional dyspepsia: a prospective pilot study.
    Pellicano R; Strona S; Simondi D; Reggiani S; Pallavicino F; Sguazzini C; Bonagura AG; Rizzetto M; Astegiano M
    Minerva Gastroenterol Dietol; 2009 Sep; 55(3):227-35. PubMed ID: 19829282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabeto plus: a valuable drug for managing functional dyspepsia.
    Ghosh A; Halder S; Mandal S; Mandal A; Basu M; Dabholkar P
    J Indian Med Assoc; 2008 Nov; 106(11):752-4. PubMed ID: 19368103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of supplements in functional dyspepsia after treatment of Helicobacter pylori.
    Pellicano R; Ribaldone DG; Saracco GM; Leone N; De Angelis C; Arrigoni A; Morello E; Sapone N; Cisarò F; Astegiano M
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):263-8. PubMed ID: 25384804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Using gaviscon preparation for relief of esophageal, extraesophageal syndromes and functional dyspepsia in elderly patients with GERD].
    Onuchina EV; Brikova SI; Tsukanov VV
    Eksp Klin Gastroenterol; 2010; (10):80-6. PubMed ID: 21434379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a muscarinic M3 receptor agonist on gastric motility.
    Chiba T; Kudara N; Sato M; Inomata M; Orii S; Suzuki K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2039-41. PubMed ID: 17914991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
    Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH
    Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of itopride in the symptoms of functional dyspepsia in Russia: results of a phase IV prospective open-label multicenter clinical trial].
    Kas'ianenko VI; Denisov NL; Vasil'ev IuV
    Ter Arkh; 2014; 86(8):35-41. PubMed ID: 25306742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment prediction of symptom response to proton pump inhibitor therapy.
    Nagahara A; Miwa H; Asaoka D; Shimada Y; Sasaki H; Matsumoto K; Osada T; Hojo M; Watanabe S
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():25-30. PubMed ID: 25827800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
    Sakaguchi M; Takao M; Ohyama Y; Oka H; Yamashita H; Fukuchi T; Ashida K; Murotani M; Murotani M; Majima K; Morikawa H; Hashimoto T; Kiyota K; Esaki H; Amemoto K; Isowa G; Takao F
    World J Gastroenterol; 2012 Apr; 18(13):1517-24. PubMed ID: 22509084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
    Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed bowel habits in patients with non-ulcer dyspepsia.
    Hammer J; Talley NJ
    Aliment Pharmacol Ther; 2006 Jul; 24(2):405-10. PubMed ID: 16842468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia.
    Nagahara A; Asaoka D; Hojo M; Oguro M; Shimada Y; Ishikawa D; Osada T; Kawabe M; Yoshizawa T; Otaka M; Watanabe S
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S122-8. PubMed ID: 20586853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ranitidine therapeutically effective in functional dyspepsia with reflux-like symptoms].
    Jebbink HJ; Smout AJ; van Berge Henegouwen GP
    Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1772-5. PubMed ID: 8371822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial.
    Boeckxstaens GE; Beaumont H; Hatlebakk JG; Silberg DG; Björck K; Karlsson M; Denison H
    Gut; 2011 Sep; 60(9):1182-8. PubMed ID: 21402616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Helicobacter pylori eradication on dyspeptic symptoms, acid reflux and quality of life in patients with functional dyspepsia.
    Bektas M; Soykan I; Altan M; Alkan M; Ozden A
    Eur J Intern Med; 2009 Jul; 20(4):419-23. PubMed ID: 19524187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cisapride on dysmotility-like functional dyspepsia: reduction of the fasting and postprandial area, but not of the postprandial antral expansion.
    Eberl T; Barnert J; Dumitrascu DL; Fischer J; Wienbeck M
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):991-5. PubMed ID: 9895043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease.
    Sarnelli G; De Giorgi F; Efficie E; Aprea G; Masone S; Savarese MF; Esposito I; Russo L; Cuomo R
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):264-8. PubMed ID: 18334868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyspepsia.
    Moayyedi P
    Curr Opin Gastroenterol; 2012 Nov; 28(6):602-7. PubMed ID: 22918384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.